- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04185701
Comparison of Subjective Refraction Measurement With SiVIEW Software and by an Expert
Study of the Subjective Refraction Measured With SiVIEW Software Compared to That Obtained Manually by an Expert. Monocentric Cross-sectional Study
Main objective
Show that the equivalent sphere refraction measurements obtained by the SiVIEW software have no significant clinical difference with those obtained by an optometrist expert.
Secondary objectives
Show that the sphere refraction measurements obtained by the SiVIEW software have no significant clinical difference with those obtained by an optometrist expert.
Show that the cylinder refraction measurements obtained by the SiVIEW software have no significant clinical difference with those obtained by an optometrist expert.
Show that the visual acuity measurements obtained by the SiVIEW software do not have a significant clinical difference with those obtained by an optometrist expert.
Demonstrate that the report delivered for each eye exam by SiVIEW software is consistent and relevant to a vision health practitioner.
Show that the differences obtained between two eye examination experts are consistent with those found in the literature.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Introduction:
Ametropia is an eye refractive disorder typically leading to myopia, hyperopia, astigmatism... 4.5 billion people are currently affected worldwide, of whom only 2 billion are corrected. Of these people, about 30% (or +/- 600,000) do not benefit from an adequate correction. From an economic point of view, the cost on productivity of the absence or poor vision correction is estimated at more than 270 billion euros / year worldwide.
Any correction of an ametropic disorder necessarily requires a precise and relevant eye examination in order to identify the disorder and determine the best possible visual correction. The procedure for this examination is identical in all countries. It must follow specific steps[Benjamin 2006; Grosvenor 2007].
At present the refraction measurement is done manually by an expert. The optical correction may vary from one examination to another, for multiple physiological and/or examination-related reasons. Several factors can cause fluctuations in subjective refraction. These include examiner and subject characteristics [Grein et al. 2014].
In addition, there is also variability due to the measurement itself, depending on each examiner. The repeatability (on the same subject) and, in addition, the reproducibility (inter-examiners) of the subjective refraction measurement related to the examiner's interpretation, examination process and experience, among other things, are therefore important data to be defined in order to know the tolerance of the measurement determined between two examinations.
In studies involving a large number of subjects, the repeatability/reproducibility limit is greater than or equal to 0.71D [Zadnik 1994, Bullimore 1998, MacKenzie 2008], and more particularly during inter-examiner measurements.
The objective of the SiVIEW solution is therefore to make the measurement of subjective refraction both repeatable and reproducible regardless of the practitioner and his expertise, by completely automating the search for the best visual prescription using an expert system that aims to make this examination simple, intuitive and reliable.
It is therefore essential to compare the SiVIEW measurement with that of an optometrist expert.
The interest of the investigator's study will be to demonstrate that the results between a refraction expert and the measurement obtained by SiVIEW are clinically similar.
Main objective:
Show that the equivalent sphere refraction measurements obtained by the SiVIEW software have no significant clinical difference with those obtained by an optometrist expert.
Secondary objectives
Show that the sphere refraction measurements obtained by the SiVIEW software have no significant clinical difference with those obtained by an optometrist expert.
Show that the cylinder refraction measurements obtained by the SiVIEW software have no significant clinical difference with those obtained by an optometrist expert.
Show that the visual acuity measurements obtained by the SiVIEW software do not have a significant clinical difference with those obtained by an optometrist expert.
Demonstrate that the report delivered for each eye exam by SiVIEW software is consistent and relevant to a vision health practitioner.
Show that the differences obtained between two eye examination experts are consistent with those found in the literature.
Plan of the study:
It is a comparative prospective open monocentric cross-sectionnal study.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Laure Pichereau
- Phone Number: (+33) 638949740
- Email: laure@siview.fr
Study Locations
-
-
-
Paris, France
- Ophthalmological Foundation A. de Rothschild
-
Contact:
- Damien Gatinel, MD
- Phone Number: (+33)148036482
- Email: ebarbosa@for.paris
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- subject with visual AV on each eye >= 8/10 and no amblyopia
- subject with normal environmental transparency
- subject with a healthy fundus that does not reveal major abnormalities that may affect vision
- subject able to read the letters of the Latin alphabet
- subject without heavy drug treatment that may affect vision as synthetic antimalarials, corticosteroids
- non-diabetic subject
- non nystagmic subject
- non-strabic subject
- subject who has not had eye surgery less than 1 year old
Exclusion Criteria:
- subject with a topography showing an anomaly (keratoconus type or other)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Eye examination by expert and SiVIEW software
Eye examination by an expert and by a technician with the SiVIEW system.
|
Eye examination by a technician with the SiVIEW software
Eye examination by an expert including optimal correction in distance and near vision
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Equivalent sphere measurement
Time Frame: At time of inclusion
|
The subject will have an eye exam with SiVIEW and an examination by an optometrist expert.
The equivalent sphere value will be evaluated in both cases.
|
At time of inclusion
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Sphere measurement
Time Frame: At time of inclusion
|
The subject will have an eye exam performed with SiVIEW and by an optometrist expert.
The sphere value will be evaluated in both cases.
The examination will be started in both cases on the objective measurement value obtained during the routine care examination.
|
At time of inclusion
|
Cylinder measurement
Time Frame: At time of inclusion
|
The subject will have an eye exam performed with SiVIEW and by an optometrist expert.
The cylinder value will be evaluated in both cases.
The examination will be started in both cases on the objective measurement value obtained during the routine care examination.
|
At time of inclusion
|
Visual acuity
Time Frame: At time of inclusion
|
The subject will have an eye exam performed with SiVIEW and by an optometrist expert.
The value of visual acuity will be assessed in both cases.
|
At time of inclusion
|
Consistency and relevance of the SiVIEW report
Time Frame: At time of inclusion
|
After each examination, the report edited by the SiVIEW software will be scored consistently on a Likert scale from 1 to 5 by an expert optometrist: 1: very inconsistent / 2: inconsistent / 3: no opinion / 4: consistent / 5: very consistent After each examination, the report edited by SiVIEW software will be scored in relevance on a 5 item Likert scale by an expert optometrist: 1: not relevant / not very relevant / no opinion / relevant / very relevant. |
At time of inclusion
|
Measurement between two optometrist experts
Time Frame: At time of inclusion
|
Each subject will have an eye examination conducted with an optometrist from the current care centre and by an optometrist expert mandated by SiVIEW (who is used to working at the Rothschild Foundation in clinical studies, among others).
The equivalent sphere value will be evaluated in both cases.
|
At time of inclusion
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Damien Gatinel, MD, Head of Department Ophthalmological Foundation A. de Rothschild, Paris, France
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SiVIEW_refraction_Paris_study
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Eye Diseases
-
University of Alabama at BirminghamPfizerCompletedVision | Eye Disease | Eye CareUnited States
-
TBF Genie TissulaireCompletedEnucleated; Eye | Eye CancerFrance
-
Kao (Taiwan) CorporationChang Gung Memorial HospitalCompletedEye Fatigue | Dry Eye SymptomTaiwan
-
National Eye Institute (NEI)RecruitingInherited Eye DiseaseUnited States, United Kingdom, China, Pakistan, Philippines, Ukraine, India, Italy
-
National Eye Institute (NEI)Recruiting
-
National Eye Institute (NEI)RecruitingGenetic Eye DiseaseUnited States
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Assistance Publique - Hôpitaux de ParisCompleted
-
OptovueCompletedNo Eye DiseaseUnited States, United Kingdom
-
National Eye Institute (NEI)CompletedHereditary Eye DiseaseUnited States
Clinical Trials on SiVIEW software
-
Hams Hamed AbdelrahmanCompletedAccuracy of Digital Dental ModelEgypt
-
University of California, San FranciscoRecruitingMild Cognitive Impairment | Long-Term Memory DeclineUnited States
-
The Methodist Hospital Research InstituteNational Institute on Aging (NIA)CompletedVirtual RealityUnited States
-
Cairo UniversityRecruitingSegmentation; BoneEgypt
-
Wuhan Union Hospital, ChinaCompleted
-
Methinks Software SLNot yet recruitingBrain Ischemia | Stroke, Ischemic | Stroke, Acute | Stroke Hemorrhagic
-
Madigan Army Medical CenterTelemedicine & Advanced Technology Research Center; Analytics4Medicine, Inc.Unknown
-
ProlaioRecruitingHeart Failure | Cardiomyopathy, Hypertrophic | Left Ventricular HypertrophyUnited States
-
Medical Decision Logic, Inc.Unknown
-
Docbot, Inc.RecruitingColorectal Adenoma | Colorectal Adenocarcinoma | Colorectal Polyp | Colorectal SSAUnited States